Table 2 Patients at risk according to Dutch CV-RM guideline risk scores and treatment
From: Cardiovascular risk management in patients with active Ankylosing Spondylitis: a detailed evaluation
Dutch CV-RM guidelines | Total N = 254 | Indication for CV risk medication N = 51 | Inadequately or not treated N = 39 | Statins N = 7 | Antihypertensive drugs N = 27 | Both statin and antihypertensive N = 9 |
|---|---|---|---|---|---|---|
High risk >20% | 9 | 9 | 9 | 2 | 2 | 1 |
Intermediate risk 10-20% | 16 | 10 | 8 | 1 | 6 | 1 |
Low risk <10% | 105 | 24 | 14 | 1 | 16 | 5 |
Secondary CV prevention | 8 | 8 | 8 | 3 | 3 | 2 |
CV risk not determined* | 116 | N.A. | N.A. | 0 | 0 | 0 |